BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28686664)

  • 1. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
    Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
    PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
    Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
    Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
    Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP
    Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
    Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
    Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial.
    Nenke MA; Haylock CL; Rankin W; Inder WJ; Gagliardi L; Eldridge C; Rolan P; Torpy DJ
    Psychoneuroendocrinology; 2015 Jun; 56():157-67. PubMed ID: 25827960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
    Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
    Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
    Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
    Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
    Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
    Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial.
    Werumeus Buning J; van Faassen M; Brummelman P; Dullaart RP; van den Berg G; van der Klauw MM; Kerstens MN; Stegeman CA; Muller Kobold AC; Kema IP; Wolffenbuttel BH; van Beek AP
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency.
    Hayashi R; Tamada D; Murata M; Kitamura T; Mukai K; Maeda N; Otsuki M; Shimomura I
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5814-5822. PubMed ID: 31290981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
    Harbeck B; Danneberg S; Rahvar AH; Haas CS; Lehnert H; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
    Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial.
    Sorgdrager FJH; Werumeus Buning J; Bos EH; Van Beek AP; Kema IP
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3411-3419. PubMed ID: 29982583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.